NCT05760144View on ClinicalTrials.gov

Endometrial Biopsy in Progestin Contraceptive Users

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

July 1, 2023

Primary Completion Date

November 30, 2026

Study Completion Date

November 30, 2026

Conditions
Contraception
Interventions
DRUG

DMPA

The participant will receive the contraceptive injectable, Depo-Provera at the enrollment visit and at 3, 6, 9, and 12 months. Participants will have endometrial biopsies at the enrollment visits and at 3, 6, and 12 months.

DRUG

Etonogestrel implant

The participant will receive the contraceptive implant, Nexplanon at the enrollment visits and have endometrial biopsies at the enrollment visits and at 3, 6, and 12 months.

Trial Locations (1)

97239

RECRUITING

OHSU, Portland

All Listed Sponsors
lead

Oregon Health and Science University

OTHER